This full paper has just become available and it is an important topic, unfortunately.
'Refractory CLL has been defined as no response or response lasting < 6 months from last therapy. This subgroup has a very poor outcome, and many trials use this group
as an entry point for early drug development.'
PDF File bloodjournal.hematologylibr...